Advertisement

Advertisement

TSE:MIR Stock Latest News

Company AnnouncementsMedMira Expands McKesson Partnership as Quarterly Revenue Falls and Loss Widens

MedMira Narrows Loss as New Syphilis Test Wins Approval and MiROQ Platform Advances

PremiumCompany Announcements

MedMira Narrows Loss as New Syphilis Test Wins Approval and MiROQ Platform Advances

4M ago

MedMira Inc. Reports FY2025 Financial Results and Strategic Developments

PremiumCompany Announcements

MedMira Inc. Reports FY2025 Financial Results and Strategic Developments

5M ago

Health Canada Approves MedMira’s Rapid Syphilis Test Amid Rising Cases

PremiumCompany Announcements

Health Canada Approves MedMira’s Rapid Syphilis Test Amid Rising Cases

8M ago

MedMira Launches Clinical Trial for HIV/Syphilis Self-Test in Canada

PremiumCompany Announcements

MedMira Launches Clinical Trial for HIV/Syphilis Self-Test in Canada

9M ago

MedMira Reports Q2 FY2025 Results, Advances in STI and HIV Testing

PremiumCompany AnnouncementsMedMira Reports Q2 FY2025 Results, Advances in STI and HIV Testing

10M ago

MedMira Partners with Lovell to Enhance Federal Access to Rapid HIV Testing

Company Announcements

MedMira Partners with Lovell to Enhance Federal Access to Rapid HIV Testing

12M ago

MedMira Achieves Regulatory Milestones Amidst Financial Challenges in Q2 FY2025

Company Announcements

MedMira Achieves Regulatory Milestones Amidst Financial Challenges in Q2 FY2025

1y ago

MedMira Partners with MediGroup to Expand Reach in US Healthcare Market

PremiumCompany Announcements

MedMira Partners with MediGroup to Expand Reach in US Healthcare Market

1y ago

MedMira Partners with Trimedic to Enhance Rapid Test Distribution in Canada

PremiumCompany Announcements

MedMira Partners with Trimedic to Enhance Rapid Test Distribution in Canada

1y ago

MedMira Advances Syphilis and HIV Self-Testing in Canada

PremiumCompany Announcements

MedMira Advances Syphilis and HIV Self-Testing in Canada

1y ago

MedMira’s Rapid HIV Test Gains Health Canada Approval Amid Rising Infection Rates

PremiumCompany Announcements

MedMira’s Rapid HIV Test Gains Health Canada Approval Amid Rising Infection Rates

1y ago

MedMira Receives Authorization for Syphilis Test Clinical Trials

PremiumCompany AnnouncementsMedMira Receives Authorization for Syphilis Test Clinical Trials

1y ago

MedMira Reports Progress and Market Expansion

Company Announcements

MedMira Reports Progress and Market Expansion

1y ago

MedMira Gains Health Canada Approval for Rapid Test

Company Announcements

MedMira Gains Health Canada Approval for Rapid Test

1y ago

MedMira Expands Market with Strategic Approvals

PremiumCompany Announcements

MedMira Expands Market with Strategic Approvals

1y ago

MedMira Boosts Leadership for North American Growth

PremiumCompany Announcements

MedMira Boosts Leadership for North American Growth

2y ago

MedMira Initiates Syphilis Test Trials in Canada

PremiumCompany Announcements

MedMira Initiates Syphilis Test Trials in Canada

2y ago

Medmira Expands Reach, Faces Financial Challenges

PremiumCompany Announcements

Medmira Expands Reach, Faces Financial Challenges

2y ago

Medmira Bolsters Team for US Market Expansion

PremiumCompany AnnouncementsMedmira Bolsters Team for US Market Expansion

2y ago

Medmira Inc. Expands U.S. Presence Amidst Losses

Company Announcements

Medmira Inc. Expands U.S. Presence Amidst Losses

2y ago

Medmira Secures Patent for Diagnostic Breakthrough

Company Announcements

Medmira Secures Patent for Diagnostic Breakthrough

2y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >